IEL Intrinsic Value
IEL intrinsic value. IEL (INDXTRA) median intrinsic value is ₹8.83 from 8 valuation models (range ₹2–₹13), vs current price ₹5.20 — +69.8% upside (Trading Below Calculated Value), margin of safety 41.1%. For current market price and key ratios, visit INDXTRA share price screener.
INDXTRA Valuation Methods Summary — DCF, Graham Number & P/E
IEL intrinsic value across 8 models vs current price ₹5.20 — upside/downside and value range per method. Read IEL dividend payments for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1.56 | ₹1.25 - ₹1.87 | -70.0% | EPS: ₹0.10, Sector P/E: 12x |
| Book Value Method | asset | ₹13.00 | ₹11.70 - ₹14.30 | +150.0% | Book Value/Share: ₹34.62, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1.56 | ₹1.40 - ₹1.72 | -70.0% | Revenue/Share: ₹1.54, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹9.23 | ₹8.31 - ₹10.15 | +77.5% | EBITDA: ₹2.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹13.00 | ₹10.40 - ₹15.60 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1.56 | ₹1.40 - ₹1.72 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1.56 | ₹1.40 - ₹1.72 | -70.0% | Revenue Growth: -30.0%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹8.83 | ₹7.95 - ₹9.71 | +69.8% | EPS: ₹0.10, BVPS: ₹34.62 |
INDXTRA Intrinsic Value vs Market Price — All Valuation Models
IEL fair value range ₹2–₹13 vs current market price ₹5.20 across 8 valuation models. Compare with IEL valuation methods to assess whether the stock is under or overvalued.
INDXTRA Intrinsic Value Analysis — Undervalued or Overvalued?
IEL median intrinsic value ₹8.83, current price ₹5.20 — Trading Below Calculated Value by 69.8%, margin of safety 41.1%.
What is the intrinsic value of INDXTRA?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of IEL (INDXTRA) is ₹8.83 (median value). With the current market price of ₹5.20, this represents a +69.8% variance from our estimated fair value.
The valuation range spans from ₹1.56 to ₹13.00, indicating ₹1.56 - ₹13.00.
Is INDXTRA undervalued or overvalued?
Based on our multi-method analysis, IEL (INDXTRA) appears to be trading below calculated value by approximately 69.8%.
INDXTRA Financial Health — Key Ratios vs Industry Benchmarks
IEL financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 17.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 4.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 65.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.04x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
INDXTRA Cash Flow Quality — Operating & Free Cash Flow
IEL operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹0 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹2 Cr | ₹-9 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |